DNA

DNA Operating CF Margin

-152.19%TTM

Retrieved:

DNA FY Operating CF Margin%
DNA FY Operating CF Margin-37.87%-192.12%
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

DNA operating cf margin history

Operating cash flow as percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Ginkgo Bioworks Holdings Inc Class Operating CF Margin — Annual fiscal periods
Period endingOperating CF Margin
-100.5313%
-140.7597%
-117.5161%
-52.7936%
-80.8757%
-177.1919%
-82.4284%

Compare operating cf margin

All DNA financial metrics · DNA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.